MASHINIi

Galecto, Inc..

GLTO.US | Research and experimental development on natural sciences and engineering

Galecto, Inc. is a biotechnology company focused on developing novel treatments for fibrosis and cancer. The company's primary focus is on galectin modulators, which are molecules that can modulate the activity of galectins, a family of proteins involved in various biological processes, including in...Show More

Ethical Profile

Mixed.

Galecto, Inc. holds a mixed ethical profile. Auditors noted a "material uncertainty" regarding its subsidiary, Galecto Biotech ApS, to continue as a going concern due to financing dependence. As a clinical-stage biotechnology company, its drug development inherently involves animal testing, a common industry practice. While focused on creating therapeutics for serious diseases like fibrosis and cancer, the ultimate impact on "Better Health for All" depends on drug accessibility and affordability. The company also handles sensitive patient data in clinical trials, necessitating robust data protection and GDPR compliance.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Galecto, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Galecto, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess Galecto, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No specific data points or information regarding Galecto, Inc.'s fair trade practices, ethical sourcing, supply chain audits, forced or child labor incidents, supply chain traceability, remediation processes, ethical clauses in supplier contracts, materials risk, or supplier diversity spend were found in the provided articles.

1
Therefore, no KPIs for Fair Trade & Ethical Sourcing can be scored.

Honest & Fair Business

0

No specific, quantifiable evidence was found in the provided article to assess Galecto, Inc. against the defined KPIs for Honest & Fair Business. The article primarily details the financial performance and audit opinion for its subsidiary, Galecto Biotech ApS, and does not provide company-wide data for regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage percentage for the parent company, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification of ethical claims.

1

Kind to Animals

0

No evidence available to assess Galecto, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess Galecto, Inc. on No War, No Weapons.

Planet-Friendly Business

0

The provided articles, which include SEC filings and an annual report, do not contain any specific information or data points relevant to the 'Planet-Friendly Business' ethical value or its associated Key Performance Indicators.

1
The documents primarily focus on financial performance, business operations, and clinical development, explicitly stating the absence of environmental, social, or governance (ESG) metrics.
2

Respect for Cultures & Communities

0

No evidence available to assess Galecto, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

No evidence available to assess Galecto, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, concrete data points or initiatives related to GLTO.US (Galecto, Inc.) regarding waste management, product sustainability, or circular economy practices were found in the provided articles. The articles discuss general industry trends or the practices of other companies (Azenta, BioEcho, and Corning), none of which are identified as GLTO.US.

Own Galecto, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.